The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
A Test in Context
Open accessAbstract
The inflammatory biomarker high-sensitivity C-reactive protein (hsCRP) adds prognostic information on cardiovascular risk comparable to blood pressure or cholesterol. Values <1, 1 to 3, and >3 mg/l indicate lower, average, or higher relative cardiovascular risk, respectively. Global risk algorithms that include hsCRP outperform those solely using Framingham covariates. Although diet, exercise, and smoking cessation are first steps for patients with a proinflammatory response, JUPITER (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) trial data demonstrate that statins reduce by 47% the rate of first myocardial infarction, stroke, or confirmed cardiovascular death when given to patients with low-density lipoprotein-C levels of <130 mg/dl and hsCRP of >2 mg/l (hazard ratio: 0.53; 95% confidence interval: 0.40 to 0.69; p < 0.00001). In current U.S. guidelines, hsCRP carries a class IIb assessment and is most appropriate in primary prevention when clinical decisions to initiate statin therapy are uncertain. Ongoing multinational trials are pursuing whether reducing inflammation will decrease vascular event rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These hsCRP categories are also used to predict CV outcomes [8].”
From Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials (2022) · cites this paper as [8]
In the citing paper
“the inflammatory biomarker high-sensitivity C-reactive protein (CRP) is a predictor of cardiovascular events in men and women40.”
From Chronic inflammation in the etiology of disease across the life span (2019) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Self-citationRidker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Self-citationInflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Self-citationEzetimibe Added to Statin Therapy after Acute Coronary Syndromes
Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., Darius, H., Lewis, B. S., Ophuis, T. O., Jukema, J. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410489 · Cited by 4,487
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Self-citationType 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J. J., Gotto, A. M., Kastelein, J. J. P., Köenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Self-citationRidker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 417
Funderburg, N., McComsey, G. A., Kulkarni, M., Bannerman, T. L., Mantini, J., Thornton, B., Liu, H. C., Zhang, Y., Song, Q., Fang, L., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.10.009 · Cited by 25
Cabral, M., Bangdiwala, S. I., Severo, M., Guimarães, J. T., Nogueira, L., & Ramos, E. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.05.066 · Cited by 24
Ladehesa-Pineda, L., de la Rosa, I. A., López‐Medina, C., Castro, C., Ábalos-Aguilera, M. D. C., Castro, R. O., Gómez‐García, I., Azpilcueta, P. S., Jiménez, Y., Escudero‐Contreras, A., et al. (2020) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x20982837 · Cited by 24
Pham, C., Bekkering, S., O’Hely, M., Burgner, D. P., Thomson, S. M., Vuillermin, P., Collier, F., Marx, W., Mansell, T., Symeonides, C., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.05.011 · Cited by 24
Habánová, M., Holovičová, M., Scepankova, H., Lorková, M., Gazo, J., Gažarová, M., Pinto, C. A., Saraiva, J. A., & Estevinho, L. M. (2022) · Antioxidants · doi:10.3390/antiox11112239 · Cited by 24
The Usefulness of Selected Biomarkers in Patients With Valve Disease
Duchnowski, P., Hryniewiecki, T., Kuśmierczyk, M., & Szymański, P. (2018) · Biomarkers in Medicine · doi:10.2217/bmm-2018-0101 · Cited by 24
Lyra, P., Botelho, J., Machado, V., Rota, S., Walker, R., Staunton, J., Proença, L., Chaudhuri, К. R., & Mendes, J. J. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00302-1 · Cited by 23
Mass spectrometry-based approaches to targeted quantitative proteomics in cardiovascular disease
Mesaros, C., & Blair, I. A. (2016) · Clinical Proteomics · doi:10.1186/s12014-016-9121-1 · Cited by 23
Inflammation and ischemic heart disease: The next therapeutic target?
Vilela, E., & Fontes‐Carvalho, R. (2021) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repc.2021.02.011 · Cited by 25
Prediction value of pericoronary fat attenuation index for coronary in-stent restenosis
Lu, Z.-F., Yin, W., Schoepf, U. J., Abrol, S., Ma, J.-W., Zhao, L., Su, X., An, Y., Xiao, Z.-C., & Lü, B. (2024) · European Radiology · doi:10.1007/s00330-023-10527-0 · Cited by 22
Anti-inflammatory effects of tirzepatide: a systematic review and meta-analysis
Masson, W., Lobo, M., Nogueira, J. P., Barbagelata, L., Touzas, P., & Frías, J. P. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-09991-4 · Cited by 21
Song, E. K., & Kang, S. (2016) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000000389 · Cited by 21
Ziv‐Baran, T., Wasserman, A., Goldiner, I., Stark, M., Shenhar‐Tsarfaty, S., Shapira, I., Zeltser, D., Mailis, I., Berliner, S. A., & Rogowski, O. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.12.002 · Cited by 21
Araki, E., Tanaka, A., Inagaki, N., Ito, H., Ueki, K., Murohara, T., Imai, K., Sata, M., Sugiyama, T., Ishii, H., et al. (2020) · Circulation Journal · doi:10.1253/circj.cj-20-0865 · Cited by 24
High-sensitive C-reactive protein in patients with coronary artery disease
Patil, V. C., Avhad, A., Kulkarni, A., & Pandere, K. (2020) · Journal of Natural Science Biology and Medicine · doi:10.4103/jnsbm.jnsbm_159_19 · Cited by 20
Chen, X., Zhou, J., Fang, M., Yang, J. Y., Wang, X., Wang, S., & Yang, L. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.902108 · Cited by 20
Zhang, J., Ji, C., Zhai, X., Tong, H., & Hu, J. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1038738 · Cited by 20
Sustained Focal Vascular Inflammation Accelerates Atherosclerosis in Remote Arteries
Lavín, B., Phinikaridou, A., Andía, M. E., Potter, M., Lorrio, S., Rashid, I., & Botnar, R. M. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314387 · Cited by 20
Lipoprotein(a), Immunity, and Inflammation in Polyvascular Atherosclerotic Disease
Tmoyan, N. A., Afanasieva, O. I., Владиславович, Е. М., Klesareva, E., Balakhonova, T. V., & Pokrovsky, S. N. (2021) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd8020011 · Cited by 22
Kim, J., Pyo, S. S., Yoon, D. W., Lee, S., Lim, J.-Y., Heo, J. S., Lee, S. K., & Shin, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206157 · Cited by 20
Mild Systemic Inflammation Increases Erythrocyte Fragility
Stuart, C. M., Jacob, C., Varatharaj, A., Howard, S., Chouhan, J. K., Teeling, J. L., & Galea, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137027 · Cited by 19
Tamaddoni, A., Nasseri, E., Mohammadi, E., Qujeq, D., Zayeri, F., Zand, H., Mir, S. M., & Gholami, M. (2019) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2019.100324 · Cited by 19
Pang, R., Zhu, Q., Wei, J., Wang, Y., Feng-qin, X., Meng, X., & Wang, Z. (2021) · RSC Advances · doi:10.1039/d1ra04404d · Cited by 19
Temporal relationship between inflammation and metabolic disorders and their impact on cancer risk
Liu, C., Liu, T., Zhang, Q., Song, M., Zhang, Q., Shi, J., Deng, L., Chen, Y., Zheng, X. M., Lin, S., et al. (2024) · Journal of Global Health · doi:10.7189/jogh.14.04041 · Cited by 19
Chen, R., Li, J., Zhou, J., Wang, Y., Zhao, X., Li, N., Liu, W., Liu, C., Zhou, P., Chen, Y., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106618 · Cited by 18
Malnutrition and sarcopenia worsen short- and long-term outcomes in internal medicine inpatients
Carretero‐Gómez, J., Fernández, T. F. G., Ríos, A. S. V., Palacios, M. R. P., García, G. M. G., Carrasco, C. G., Requena, J. M. R., Recio, J. M. F., López-Alegría, L. N., Pijierro-Amador, A., et al. (2023) · Postgraduate Medical Journal · doi:10.1093/postmj/qgad006 · Cited by 18
Bertero, E., Carmisciano, L., Jonasson, C., Butler, J., Maack, C., & Ameri, P. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae089 · Cited by 18
Role of circulating factors in cardiac aging
Cannata, A. N., Marcon, G., Cimmino, G., Camparini, L., Ciucci, G., Sinagra, G., & Loffredo, F. S. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.03.95 · Cited by 20
Belcaro, G. V., Cornelli, U., Cesarone, M. R., SCIPIONE, C., SCIPIONE, V., Hu, S., Feragalli, B., Corsi, M., David, C. O. X., Cotellese, R., et al. (2022) · Minerva Medica · doi:10.23736/s0026-4806.21.07650-3 · Cited by 17
Adamidis, P. S., Pantazi, D., Moschonas, I. C., Liberopoulos, E. N., & Tselepis, A. D. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11030072 · Cited by 19
C-Reactive Protein: An Important Inflammatory Marker of Coronary Atherosclerotic Disease
Zhao, X., Cheng, G., Chen, H., Chen, X., Liu, T., & Gu, D. (2024) · Angiology · doi:10.1177/00033197241273360 · Cited by 20
Wu, K., Liang, Q., Huang, B.-T., Ding, N., Li, B., & Hao, J. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02321-w · Cited by 17
the directors of the JCS, J., Araki, E., Tanaka, A., Inagaki, N., Ito, H., Ueki, K., Murohara, T., Imai, K., Sata, M., Sugiyama, T., et al. (2020) · Diabetology International · doi:10.1007/s13340-020-00471-5 · Cited by 16
Carretero, R. G., Vigil, L., & Barquero‐Pérez, Ó. (2021) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2020.0139 · Cited by 18
Carrera‐Bastos, P., Silva, B. M. B. D. M., Stults‐Kolehmainen, M., Schuch, F. B., Ordóñez, F. M., Müller, P. D. T., Blanco, J. R., & Boullosa, D. A. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1554062 · Cited by 19
Cardiovascular Risk Factors in Patients With Congenital Heart Disease
Bigras, J. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.06.013 · Cited by 16
Identification of oxidative stress-related genes and potential mechanisms in atherosclerosis
Tang, C. K., Deng, L. W., Luo, Q., & He, G. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.998954 · Cited by 16
Guo, X., Lin, K., Li, H., Chen, J., Zhou, Y., Liu, Y., Tan, N., Atkins, E., Ran, P., Yang, J., et al. (2016) · Angiology · doi:10.1177/0003319716674623 · Cited by 16
Beyhoff, N., Cao, D., Mehran, R., Dangas, G., Baber, U., Sartori, S., Blum, M., Roumeliotis, A., Chandiramani, R., Goel, R., et al. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.09.024 · Cited by 16
Cardiovascular Disease Complicating COVID-19 in the Elderly
Dayaramani, C., Leon, J. D., & Reiss, A. B. (2021) · Medicina · doi:10.3390/medicina57080833 · Cited by 16
Minami, Y., Kajimoto, K., Sato, N., & Hagiwara, N. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.12.046 · Cited by 16
Lv, L., Rajpura, J. R., Liu, M., Strum, M., Chastek, B. J., Johnson, J., & Gluckman, T. J. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.100950 · Cited by 15
Singh, A., Riaz, R., Verma, A., Irfan, H., Shaukat, A. F., Nadeem, A., Goyal, P., Habib, A., & Satapathy, P. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003391 · Cited by 16
Lam, S. H. M., So, H., Cheng, I. T., Li, E. K., Wong, P. C. H., Li, T. K., Lee, A. P., & Tam, L. (2021) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x211027712 · Cited by 15
Khan, S. R., Dalm, V. A. S. H., Ikram, M. K., Peeters, R. P., van Hagen, P. M., Kavousi, M., & Chaker, L. (2023) · Journal of Clinical Immunology · doi:10.1007/s10875-023-01433-7 · Cited by 15
Aneni, E. C., Bittencourt, M. S., Teng, C., Cainzos‐Achirica, M., Osondu, C. U., Soliman, A., Al-Mallah, M. H., Buddoff, M. J., Parise, E. R., Santos, R. D., et al. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100097 · Cited by 15
He, L., Yang, N., Ping, F., Xu, L., Li, W., Li, Y., & Zhang, H. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s265465 · Cited by 15
Hansen, K. E., Murali, S. G., Zúñiga-Chaves, I., Suen, G., & Ney, D. M. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.03.014 · Cited by 15
Fan, L., Liu, B., Guo, R., Luo, J., Li, H., Li, Z., & Xu, W. (2019) · International Journal of Medical Sciences · doi:10.7150/ijms.35037 · Cited by 15
Monneret, D., Mestari, F., Djiavoudine, S., Bachelot, G., Cloison, M., Imbert‐Bismut, F., Bernard, M., Hausfater, P., Lacorte, J., & Bonnefont‐Rousselot, D. (2018) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2018.1471618 · Cited by 14
Acidic pH promotes oxidation-induced dissociation of C-reactive protein
Li, S., Feng, J.-R., Zhou, H., Zhang, C., Lv, G.-B., Tan, Y.-B., Ge, Z.-B., & Wang, M. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.09.021 · Cited by 14
Kjaergaard, A. D., Helby, J., Johansen, J. S., Nordestgaard, B. G., & Bojesen, S. E. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.01.010 · Cited by 14
DUSP1 Is a Potential Marker of Chronic Inflammation in Arabs with Cardiovascular Diseases
Khadir, A., Kavalakatt, S., Dehbi, M., Alarouj, M., Bennakhi, A., Tiss, A., & Elkum, N. B. (2018) · Disease Markers · doi:10.1155/2018/9529621 · Cited by 15
High-sensitivity C-reactive protein mediates age-related vascular dysfunction: the Rotterdam study
Jouabadi, S. M., Claringbould, A., Danser, A. H. J., Stricker, B. H. C., Kavousi, M., Roks, A. J. M., & Ahmadizar, F. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf370 · Cited by 17
Safety and pharmacokinetics of the non-hormonal male contraceptive YCT-529
Mannowetz, N., McCallum, S. W., Sidhu, S., Mena, K. H., Ruby, E., Castro‐Santamaria, R., Dodds, E., Henderson, D., Whitaker, G., Wright, H., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-01004-4 · Cited by 13
Liu-Galvin, R. E., Orlando, F. A., Saguil, A. A., Jo, A., Smith, K., Miller, A. M., Nelson, D. S., Sanders, E. C., & Mainous, A. G. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1695935 · Cited by 14
Gumede, N. P., & Khathi, A. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1256427 · Cited by 13
Wu, D., Lan, Y., Chen, S., Ding, X., Chen, G., Wu, C., Balmer, L. A., Xu, W., Wu, S., & Wang, W. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02067-0 · Cited by 13
Li, Q., Song, Y., Zhang, Z., Xu, J., Liu, Z., Tang, X., Wang, X., Chen, Y., Zhang, Y., Zhu, P., et al. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.13589 · Cited by 13
Shi, L., Lam, S. H. M., So, H., Li, E. K., Li, T. K., Szeto, C., & Tam, L. (2022) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x221122401 · Cited by 13
Expanding the therapeutic landscape: ezetimibe as non-statin therapy for dyslipidemia
Lee, J., & Lee, S. (2023) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2023.243 · Cited by 15
Saelee, R., Alexander, D. S., Onufrak, S. J., Imperatore, G., & Bullard, K. M. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.12.041 · Cited by 13
Thromboelastography Values Remain Hypercoagulative 6 Months After Obesity Surgery: a Pilot Study
Tuovila, M., Erkinaro, T. M., Koivukangas, V., Savolainen, E., Laurila, P., Ohtonen, P. P., & Ala-Kokko, T. I. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3437-z · Cited by 13
The association between high-sensitivity C-reactive protein and blood pressure in Yi people
Pan, L., Li, G., Wan, S., Yihuo, W.-L., Yang, F., Li, Z., & Shan, G. (2019) · BMC Public Health · doi:10.1186/s12889-019-7324-x · Cited by 13
Rosenberg, N., Daviglus, M. L., DeVon, H. A., Park, C. G., & Eldeirawi, K. M. (2017) · Women s Health Issues · doi:10.1016/j.whi.2017.03.002 · Cited by 13
Bala, C. G., Rusu, A., Ciobanu, D. M., Craciun, A. E., & Román, G. (2018) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s162086 · Cited by 12
Park, S. W., Park, S., Kim, E., Sung, W.-S., Ha, I., & Jung, B. (2020) · Health and Quality of Life Outcomes · doi:10.1186/s12955-020-01597-5 · Cited by 12
Mid- to Late-Life Inflammation and Risk of Cardiac Dysfunction, HFpEF and HFrEF in Late Life
Cohen, A., TERAMOTO, K., Claggett, B. L., Buckley, L. F., Solomon, S. D., Ballantyne, C. M., Selvin, E., & Shah, A. M. (2021) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.07.006 · Cited by 12
Grigorescu, E.-D., Lăcătușu, C.-M., Floria, M., Cazac, G.-D., Onofriescu, A., Ceasovschih, A., Crețu, I., Mihai, B. M., & Șorodoc, L. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091484 · Cited by 12
Chu, X., Feng, B., Ge, J., Guo, L., Huo, Y., Ji, L., Jia, Q., Jiang, S., Li, Y., Liu, F., et al. (2022) · Cardiology Plus · doi:10.1097/cp9.0000000000000029 · Cited by 12
Tokgözoğlu, L. S., Morrow, D. A., & Nicholls, S. J. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad275 · Cited by 12
Jain, V., Mehta, A., Lee, T. B., Liu, C., Chew, N., Ko, Y., Gold, M. E., Gold, D. A., Vatsa, N., Desai, S., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.031230 · Cited by 12
Sandwich NP-based biobarcode assay for quantification C-reactive protein in plasma samples
Broto, M., Galvé, R., & Marco, M. ‐. (2017) · Analytica Chimica Acta · doi:10.1016/j.aca.2017.09.007 · Cited by 12
Italian Society of Echocardiography and Cardiovascular Imaging (SIECVI), Fabiani, I., Pugliese, N. R., Carrubba, S. L., Conte, L., Colonna, P., Caso, P., Benedetto, F. A., Antonini‐Canterin, F., Citro, R., et al. (2019) · International journal of cardiac imaging · doi:10.1007/s10554-019-01560-6 · Cited by 12
Davids, S. F. G., Matsha, T. E., Peer, N., Erasmus, R. T., & Kengne, A. P. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3781214 · Cited by 12
Wu, D., Chen, G., Lan, Y., Chen, S., Ding, X., Wei, C., Balmer, L. A., Wang, W., Wu, S., & Xu, W. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-04895-4 · Cited by 11
Lian, P., Xie, F., Zhang, W., Cheng, S., Zhao, Y., Li, D., Liang, S.-F., Zhu, Z.-Z., Zhang, J.-Y., Cui, J.-J., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1618157 · Cited by 11
Kim, J., Jeong, K., Lee, S., & Baek, Y. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/3631445 · Cited by 11
Bachetti, T., Bardile, A. F., Aloi, T. L., Colombo, B., Assi, E., Savino, G., Vercelli, A., Colombo, R., & Corti, A. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.02.019 · Cited by 11
Cabral, M., Severo, M., Barros, H., Guimarães, J. T., & Ramos, E. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.03.008 · Cited by 11
Freitas, A. T. A., Giraldo, A. E. D., Rezende, G. P., Yela, D. A., Jales, R. M., & Benetti‐Pinto, C. L. (2020) · Clinical Endocrinology · doi:10.1111/cen.14331 · Cited by 11
Kim‐Mitsuyama, S., Soejima, H., Yasuda, O., Node, K., Jinnouchi, H., Yamamoto, E., Sekigami, T., Ogawa, H., & Matsui, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-73905-4 · Cited by 12
Cardiovascular risk assessment and screening in diabetes
Zhao, Y. (2017) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000115 · Cited by 11
Heilmeier, U., Feldmann, D., Leynes, A. P., Seng, M., Jandova, I., Keute, M., Kollert, F., Voll, R. E., & Finzel, S. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1446268 · Cited by 11
A review of cutting-edge biomarkers for diagnosing coronary artery disease
Azami, P., Mohammadzadeh, S., Seirafi, S., & Razeghian‐Jahromi, I. (2025) · Medicine · doi:10.1097/md.0000000000041377 · Cited by 13
Khan, A. H. K. Y., Zakaria, N. F., Abidin, M. A. Z., Lim, C. T. S., & Kamaruddin, N. A. (2020) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.035.01.12 · Cited by 11
High-Risk Obesity Phenotypes: Target for Multimorbidity Prevention at the ROFEMI Study
Carretero‐Gómez, J., Pérez-Martínez, P., Seguí‐Ripoll, J. M., Carrasco-Sánchez, F. J., Martínez, N. L., Pérez, E. F., Hernández, O. P., Ordoñez, M. G., Martín‐González, C., Vigueras-Pérez, J., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164644 · Cited by 10
Willinger, L., Brudy, L., Häcker, A., Meyer, M., Hager, A., Oberhoffer, R., Ewert, P., & Müller, J. (2023) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvad032 · Cited by 10
Aday, A. W., Bagheri, M., Vaitinadin, N. S., Mosley, J. D., & Wang, T. J. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117194 · Cited by 9
SARS‐CoV‐2 infection and long COVID among California farmworkers
Mora, A. M., Kogut, K. R., Sandhu, N. K., Ridgway, D., Patty, C. M., Renteria, M., Morga, N., Rodríguez, M. T. G., Romero, M., Valdovinos, J. M., et al. (2023) · The Journal of Rural Health · doi:10.1111/jrh.12796 · Cited by 10
Wang, Z., Li, G., Huang, R., Chang, L., Gong, C., Chen, K., & Wang, L. Y. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03530-2 · Cited by 10
Harris, C. P., Berg, A. V., Berdel, D., Bauer, C., Schikowski, T., Koletzko, S., Heinrich, J., Schulz, H., & Standl, M. (2019) · BMC Public Health · doi:10.1186/s12889-019-7113-6 · Cited by 10
Shi, L., Lam, S. H. M., So, H., Chan, C. Y., Li, T. K., Szeto, C., & Tam, L. (2023) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2023.2205056 · Cited by 10
Lund, K. P., von Stemann, J. H., Eriksson, F., Hansen, M. B., Pedersen, B. K., Sørensen, S. S., & Brüünsgaard, H. (2019) · Transplant International · doi:10.1111/tri.13425 · Cited by 10
Chen, R., Liu, C., Zhou, P., Tan, Y. T., Sheng, Z., Li, J., Zhou, J., Chen, Y., Song, L., Zhao, H., et al. (2020) · Mediators of Inflammation · doi:10.1155/2020/9343475 · Cited by 10
Orlandi, M., Pranno, N., Patel, V., Papi, P., Murro, B. D., Pompa, G., Polimeni, A., Letizia, C., Suvan, J. E., & D’Aiuto, F. (2024) · Journal of Periodontology · doi:10.1002/jper.21-0338 · Cited by 10
Silva-Luis, C. C., Lopes, M. S., Gomes, S. M., Matias, P. K. C., Brandini, F. P., da Costa, P. C. T., de Moraes, R. C. S., Martins, V. J. B., & Alves, J. L. D. B. (2024) · Nutrients · doi:10.3390/nu16223944 · Cited by 11
Cuesta-López, L., de la Rosa, I. A., Martin-Salazar, E., Barranco, A. M., Ladehesa-Pineda, L., Ruiz-Ponce, M., Puche-Larrubia, M. Á., Pérez-Sánchez, C., Segui, P., Ortega, R., et al. (2025) · RMD Open · doi:10.1136/rmdopen-2025-005746 · Cited by 9
Park, H. (2022) · Healthcare · doi:10.3390/healthcare10020361 · Cited by 9
Tippens, K. M., Erlandsen, A., Hanes, D. A., Graybill, R., Jackson, C., Briley, J., & Zwickey, H. L. (2018) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2018.0025 · Cited by 9
Metadata
- Authors
- Ridker, P. M.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Ridker, Paul M
- ORCID
- Ridker, Paul M
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2016-02
- Volume
- 67
- Issue
- 6
- Pages
- 712-723
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2264523161
- Cited by
- 414
- References
- 64
- Citations by year
- 2026: 54 · 2025: 51 · 2024: 45 · 2023: 47 · 2022: 35 · 2021: 35 · 2020: 48 · 2019: 34 · 2018: 30 · 2017: 19 · 2016: 16
- FWCI
- 6.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- AstraZeneca
- American College of Cardiology Foundation
- National Heart, Lung, and Blood Institute (U01HL101422)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- high-sensitivity C-reactive protein, inflammation, cardiovascular risk, cardiovascular risk prediction, statins, rosuvastatin, JUPITER trial, primary prevention, Framingham risk factors, LDL cholesterol, myocardial infarction, stroke, cardiovascular mortality
- MeSH terms
- C-Reactive Protein, Cardiovascular Diseases, Humans, Predictive Value of Tests, Global Health, Reproducibility of Results, Biomarkers, Incidence, Survival Rate, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review